维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="SCHROHL AS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Human epidermal growth factor receptor 2 (HER2)immunoreactivity:Specificityof three pharmaco-diagnostic antibodies显示文摘	SCHROHL AS PEDERSEN HC JENSEN SS	2011	Histopathology2011，59，5：	1
2	Tissue inhibitor of metalloproteinases-1 in breast cancer显示文摘	Würtz S Schrohl AS Srensen NM	2005	Endocr Relat Cancer2005，12，2：	1
3	Tissue inhibitor of metalloproteinases - 1 in breast cancer 显示文摘	Wurtz S? Schrohl AS Sφrensen NM	2005	Endocr Relat Cancer2005，12，2：	1
4	Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer显示文摘	Schrohl AS Holten-Andersen MN Reters HA	2004	Clin Cancer Res2004，10，7：	1
5	Measurement of the uncomplexed fraction of tissue inhibitor of metalloproteinases - 1 in the prognostic evaluation of primary breast cancer patients 显示文摘	Wurtz Sφ Christensen I J Schrohl AS	2005	Mol Cell Proteomics2005，4，4：	1
6	Primary tumor levels of tissue inhibitor of metalloproteinases - 1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer 显示文摘	Schrohl AS Meijer - van Gelder ME	2006	Clin Cancer Res2006，12，23：	1
7	Primary tumor levels of tissue inhibitor of metalloprote inases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer 显示文摘	Schrohl AS Meijer van Gelder ME Holten Andersen MN	2006	Clin Cancer Res2006，12，23：	1
8	Primary tumor levels of tissue inhibitor of metalloproteinases - 1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer显示文摘	Schrohl AS Meijervan Gelder ME Holten Andersen MN	2006	Clin Cancer Res2006，12，23：	1
9	Tissue inhibitor of metalloproteinases-1 in breast cancer显示文摘	Wurtz SO Schrohl AS Sorensen NM	2005	Endocr Relat Cancer2005，12，2：	1
10	Tissue inhibitor of metalloproteinases-1 in breast cancer 显示文摘	Wurtz SФ Schrohl AS Sφrensen NM	2005	Endocri-Relat Cancer2005，12，2：	1
11	Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer显示文摘	Schrohl AS Christensen IJ Pedersen AN	2003	Mol & Cell Proteomics2003，2，3：	1
12	Tissue inhibitor of metalloproteinases-1 in breast cancer显示文摘	Wurtz SO Schrohl AS Sφrensen NM	2005	Endocr Relat Cancer2005，12，2：	1
13	Human epidermal growth factor receptor 2(HER2)immunoreactivity:specificity of three pharmacodiagnostic antibodies显示文摘	Schrohl AS Pedersen HC Jensen SS		0，，05：	1
14	TIMP-1 as a tumor marker in breast cancer--an update显示文摘	Würtz SO Schrohl AS Mouridsen H	2008	Acta Oncol2008，47，4：	1
15	Tissue inhibitor of metalloproteinases-1 in breast cancer显示文摘	Wurtz SO Schrohl AS Sorensen NM	2005	Endoc Relat Cancer2005，12，2：	1
16	TIMP-1 as a tumor marker in breast cancer-an update显示文摘	Wurtz S0 Schrohl AS Moundsen H	2008	ActaOncol2008，，47：	1
17	Tissue inhibitor of metalloproteinases-1 in breast cancer显示文摘	Wartz S Schrohl AS Srensen NM	2005	Endocr Relat Cancer2005，12，2：	1
18	Tumor markers: From laboratory to clinical utility 显示文摘	Schrohl AS Holten-Andersen M Sweep F	2003	Mol Cell Proteomics2003，2，：	1
19	Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer显示文摘	Schrohl AS Holten Andersen MN Peters HA	2004	Clin Cancer Res2004，10，7：	1
20	Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer显示文摘	Schrohl AS Holten-Andersen MN Peters HA	2004	Clin Cancer Res2004，10，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示